Safety and efficacy results from the phase 1/2 study of U3-1402, a human epidermal growth factor receptor 3 (HER3)-directed antibody drug conjugate (ADC), in patients with HER3-expressing metastatic breast cancer (MBC)

被引:0
作者
Krop, Ian [1 ]
Yonemori, Kan [2 ]
Takahashi, Shunji [3 ]
Inoue, Kenichi [4 ]
Nakayama, Takahiro [5 ]
Iwata, Hiroji [6 ]
Toyama, Tatsuya [7 ]
Yamamoto, Yutaka [8 ]
Takahashi, Masato [9 ]
Osaki, Akihiko [10 ]
Saji, Shigehira [11 ]
Sagara, Yasuaki [12 ]
O'Shaughnessy, Joyce [13 ]
Traina, Tiffany [14 ]
Ohwada, Shoichi [15 ]
Qi, Zhenhao [16 ]
Qiu, Yang [16 ]
Onuma, Hiroshi [15 ]
Sharma, Om [16 ]
Mekan, Sabeen [16 ]
Masuda, Norikazu [17 ]
机构
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Natl Canc Ctr, Tokyo, Japan
[3] Canc Inst Hosp Japanese Fdn Canc Res, Tokyo, Japan
[4] Saitama Canc Ctr, Saitama, Japan
[5] Osaka Int Canc Inst, Osaka, Japan
[6] Aichi Canc Ctr Hosp, Nagoya, Aichi, Japan
[7] Nagoya City Univ, Nagoya, Aichi, Japan
[8] Kumamoto Univ Hosp, Kumamoto, Japan
[9] Natl Hosp Org Hokkaido Canc Ctr, Sapporo, Hokkaido, Japan
[10] Saitama Med Univ Int Med Ctr, Hidaka, Japan
[11] Fukushima Med Univ Hosp, Fukushima, Japan
[12] Hakuaikai Social Med Corp Sagara Hosp, Kagoshima, Japan
[13] Bayero Univ, US Oncol, Texas Oncol, Med Ctr, Dallas, TX USA
[14] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[15] Daiichi Sankyo Co Ltd, Tokyo, Japan
[16] Daiichi Sankyo Co Ltd, Basking Ridge, NJ USA
[17] Natl Hosp Org Osaka Natl Hosp, Osaka, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PD1-09
引用
收藏
页数:1
相关论文
empty
未找到相关数据